Interview with @JacquemontSeb about our last paper in @Brain1878 "Dissecting autism and schizophrenia through neuroimaging genomics" 🧠🧬https://t.co/vnvorX1x3W
Neuroimaging of large effect-size genetic risk for neuropsychiatric disorders is gaining traction! This robust effect and can be leveraged to link molecular function to large-scale brain networks.
Our new review in Current Opinion in Genetics & Development: Structural and functional brain alterations in #CNVs overlap with those found in idiopathic #psychiatric conditions but effect sizes are 2 to 5 fold larger @Winkytheelf @JacquemontSeb @meetkd007
https://t.co/2MqoNPaJTc
Our new review in Current Opinion in Genetics & Development: Structural and functional brain alterations in #CNVs overlap with those found in idiopathic #psychiatric conditions but effect sizes are 2 to 5 fold larger @Winkytheelf @JacquemontSeb @meetkd007
https://t.co/2MqoNPaJTc
.@EmilieWigdor: Recent work has shown:
- common variants contribute risk for neurodevelopmental disorders (work by @ma_niemi)
- years of schooling, intelligence, and schizophrenia are genetically correlated with risk for NDDs
- sig enrichment of rare, inherited variants
#GRD21
Ready to "reverse-engineer" the human brain in Montréal?
🚨#JobAlert: Post-Doc/PhD in psychiatric neurogenomics — fully funded!
Position in collaboration between @JacquemontSeb, @danilobzdok & @ppsp_team
https://t.co/Y9dNQjdzPm #PleaseRT
Rare CNV carriers may help us understand not only rare isolated syndromes, but also interrelated disorders and interaction between rare and common variants in shaping brain and disease. See how in the ENIGMA-CNV & 22q11.2 WGs’ review out today in HBM:
https://t.co/SwWhJEu3do
I'm so proud of my team, and humbled and grateful for the opportunity to contribute to our understanding of 3q29 deletion syndrome: https://t.co/KgIdVyXtLO
Study is out! High-confidence LoF mutations in a large proportion of ASD-genes show moderate relative risk for ASD and are observed in unaffected individuals. Yes, these variants are deleterious, but we overestimate their impact in the clinic!
What is the profile of carriers of autism-associated mutations in the general population? We identified such mutations among >10K autistic and >100K control individuals, but instead of focusing on the "patients", we looked at the non-autistic individuals.👉https://t.co/aUFnj5bQbh
Exome sequencing finds a genetic cause of cerebral palsy in 32.7% of pediatric patients and 10.5% of adults! 229 genes implicated in CP from our study of 1,526 patients. https://t.co/OTKXXOlmDP @JAMA_current@JAMANetwork@GeneDx@GeisingerADMI @GeisingerRads
Just wanted to share with the world how immensely proud I am that @AFiksinski brilliantly defended her #PhD thesis today. Congratulations Dr Fiksinski 🎓. You have impressed us all. Time to celebrate 🥳👏💃🕺
#22q11DS#Psychiatrygenetics#schizophrenia#autism
“It happened, therefore it can happen again: this is the core of what we have to say.”
~ Primo Levi
from “The Drowned and The Saved”
thanks to @PGourevitch
The #gnomAD browser now displays more #ClinVar data!
New features include:
- ClinVar track includes all classifications
- Clinical significance, plus links to ClinVar, added to the variant table
- ClinVar details added to the variant page
Although starting a new job and moving during a pandemic is a little weird, week 1 @StJudeResearch in #Memphis has been great! Almost (hopefully!) done orienting, training, etc. Focus for week 2: science! #epilepsy#genetics
@JacquemontSeb@Jacob_Vorstman@danilobzdok@bogglerapture@hyejung_won @Winkytheelf @sebatlab Cannot claim to know the science of it but can claim to know that effects on cognitive abilities of CNV's are well known to families who have received deletion/duplication etc diagnosis for their kids. Individually rare, collectively very common indeed - wish we were asked!